Jun 01, 2015
From the Healthcare & Life Sciences Institute
Future proofing the life sciences supply chain will require redefining the supply chain to become more agile, increasing capabilities to support demand-driven performance, and aligning value to unleash untapped assets and expertise. This report provides a clear indication about the demands of future proofing the supply chain. Planned and executed properly, the process requires a high degree of commitment, discipline and buy-in from stakeholders. It also points out that the benefits of future proofing are being demonstrated every day in global pharmaceutical markets, enabling increased revenue growth, optimized new product pipelines, improved material flows and reduced operational risk.